share_log

Context Therapeutics Says On Jan. 24 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

Benzinga Real-time News ·  Jan 27, 2023 16:06
Context Therapeutics Says On Jan. 24 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment